Table 4
Age-specific changes in five-year net survival, by selected cancer type, ages 15 to 84 years, Canada excluding Quebec, 1992-to-1994 to 2012-to-2014 period^{Table 4 Note †}

Table 4
Age-specific changes in five-year net survival, by selected cancer type, ages 15 to 84 years, Canada excluding Quebec, 1992-to-1994 to 2012-to-2014 period†
Table summary
This table displays the results of Age-specific changes in five-year net survival. The information is grouped by Cancer (appearing as row headers), Age group at diagnosis (years), 15 to 44, 45 to 54, 55 to 64, 65 to 74, 75 to 84, % point change, 95% confidence interval and p-value, calculated using from and to units of measure (appearing as column headers).
Cancer	Age group at diagnosis (years)
	15 to 44				45 to 54				55 to 64				65 to 74				75 to 84
	% point change	95% confidence interval		p-value	% point change	95% confidence interval		p-value	% point change	95% confidence interval		p-value	% point change	95% confidence interval		p-value	% point change	95% confidence interval		p-value
	% point change	from	to	p-value	% point change	from	to	p-value	% point change	from	to	p-value	% point change	from	to	p-value	% point change	from	to	p-value
Tongue	7.9	-2.7	18.5	0.146	13.9	5.9	21.9	0.001	19.6	12.9	26.3	<0.0005	15.3	7.8	22.8	<0.0005	3.3	-8.6	15.2	0.587
Esophagus	-3.5	-16.9	9.8	0.605	9.9	4.5	15.2	<0.0005	8.5	4.9	12.1	<0.0005	3.4	0.3	6.6	0.035	3.8	0.1	7.6	0.045
Stomach	4.5	-2.8	11.7	0.225	7.7	2.8	12.7	0.002	9.7	6.3	13.2	<0.0005	12.2	9.1	15.3	<0.0005	9.5	6.3	12.8	<0.0005
Small intestine	14.9	0.6	29.2	0.041	20.0	7.7	32.2	0.001	23.3	13.8	32.7	<0.0005	24.1	15.8	32.4	<0.0005	14.2	3.2	25.1	0.011
Colon	14.7	10.3	19.0	<0.0005	9.6	6.7	12.5	<0.0005	11.0	8.9	13.0	<0.0005	10.1	8.3	11.8	<0.0005	9.4	7.2	11.6	<0.0005
Rectum	10.1	4.4	15.8	0.001	15.7	12.1	19.4	<0.0005	15.4	12.8	18.1	<0.0005	12.7	10.2	15.3	<0.0005	8.1	4.6	11.7	<0.0005
Anus	-5.8	-19.0	7.5	0.394	-0.8	-11.0	9.4	0.876	8.6	-0.8	17.9	0.074	5.6	-4.3	15.4	0.268	-13.5	-27.1	0.1	0.052
Liver	24.2	13.4	35.0	<0.0005	12.3	5.6	19.0	<0.0005	13.2	8.9	17.5	<0.0005	8.8	5.3	12.4	<0.0005	7.5	3.9	11.1	<0.0005
Pancreas	21.6	13.1	30.1	<0.0005	7.6	4.0	11.2	<0.0005	5.6	3.6	7.6	<0.0005	2.5	1.0	3.9	0.001	2.1	0.6	3.6	0.006
Larynx	-2.8	-17.5	11.9	0.707	0.3	-7.5	8.2	0.931	1.6	-3.8	7.1	0.561	-3.2	-9.2	2.7	0.289	0.0	-9.8	9.8	1.000
Lung and bronchus	11.8	7.1	16.5	<0.0005	5.0	3.1	7.0	<0.0005	6.4	5.2	7.5	<0.0005	6.6	5.7	7.5	<0.0005	5.0	3.9	6.1	<0.0005
Soft tissue (including heart)	1.7	-4.5	7.8	0.594	-2.3	-10.4	5.8	0.579	5.1	-3.1	13.3	0.226	2.6	-5.6	10.8	0.538	-5.3	-16.7	6.1	0.365
Melanomas of the skin	1.9	0.2	3.7	0.028	4.0	1.7	6.3	0.001	3.3	0.7	5.9	0.012	6.2	3.0	9.5	<0.0005	6.0	0.4	11.6	0.037
Breast	9.9	8.4	11.4	<0.0005	6.8	5.7	7.9	<0.0005	7.7	6.6	8.8	<0.0005	7.6	6.4	8.8	<0.0005	3.2	1.0	5.3	0.004
Cervix uteri	2.2	-0.4	4.8	0.101	4.4	-0.8	9.6	0.095	2.4	-3.9	8.8	0.457	-3.1	-10.9	4.8	0.446	1.7	-9.7	13.1	0.771
Uterus (body, NOS)	1.2	-2.7	5.1	0.537	-1.7	-4.2	0.7	0.166	-1.0	-3.0	1.0	0.330	1.8	-0.8	4.5	0.178	-1.7	-6.5	3.1	0.485
Ovary	5.2	0.2	10.2	0.043	16.2	11.5	21.0	<0.0005	13.9	9.6	18.3	<0.0005	6.3	2.3	10.3	0.002	2.3	-2.5	7.0	0.346
Prostate	20.8	7.9	33.8	0.002	11.1	8.6	13.7	<0.0005	7.3	6.3	8.3	<0.0005	7.1	6.2	8.1	<0.0005	8.4	6.5	10.2	<0.0005
Testis	1.6	0.2	3.1	0.028	2.2	-2.7	7.1	0.381	-1.1	-11.9	9.7	0.842	15.9	-5.9	37.7	0.154	Note ..: not available for a specific reference period	Note ..: not available for a specific reference period	Note ..: not available for a specific reference period	Note ..: not available for a specific reference period
Bladder (including in situ)^{Table 4 Note ‡}	-5.6	-9.8	-1.3	0.010	2.0	-1.5	5.4	0.261	0.7	-1.8	3.2	0.588	3.6	1.2	5.9	0.003	5.1	1.9	8.4	0.002
Kidney and renal pelvis	9.1	4.9	13.4	<0.0005	14.5	10.9	18.1	<0.0005	16.1	12.9	19.2	<0.0005	10.4	7.1	13.6	<0.0005	5.7	0.5	11.0	0.030
Brain	7.6	3.1	12.1	0.001	3.1	-1.9	8.0	0.222	3.3	0.5	6.1	0.022	2.2	-0.1	4.4	0.057	-3.9	-6.8	-1.1	0.007
Thyroid	0.0	-0.5	0.5	0.882	1.6	-0.2	3.4	0.083	6.3	2.9	9.8	<0.0005	8.8	3.3	14.4	0.002	26.1	15.2	37.1	<0.0005
Hodgkin lymphoma	3.5	1.5	5.4	<0.0005	5.1	-1.8	12.1	0.148	8.9	-0.9	18.7	0.074	6.7	-5.1	18.6	0.281	11.8	-5.8	29.4	0.190
Non-Hodgkin lymphoma	22.5	19.5	25.5	<0.0005	17.6	14.4	20.8	<0.0005	22.0	19.1	24.8	<0.0005	20.9	18.1	23.6	<0.0005	20.3	16.8	23.8	<0.0005
Multiple myeloma	17.5	5.1	29.8	0.005	22.8	15.5	30.1	<0.0005	24.3	19.2	29.4	<0.0005	23.5	19.4	27.6	<0.0005	9.3	4.5	14.1	<0.0005
Chronic lymphocytic leukemia	6.5	-3.4	16.4	0.196	7.6	2.6	12.5	0.003	10.6	6.4	14.8	<0.0005	13.9	9.5	18.4	<0.0005	16.2	9.7	22.7	<0.0005
Acute myeloid leukemia	22.4	15.0	29.9	<0.0005	22.7	14.5	30.9	<0.0005	10.2	4.5	15.9	<0.0005	5.5	2.2	8.9	0.001	-1.3	-4.7	2.1	0.444
Chronic myeloid leukemia	26.9	18.9	34.8	<0.0005	44.3	33.4	55.1	<0.0005	25.6	14.8	36.4	<0.0005	32.3	23.2	41.3	<0.0005	15.4	4.7	26.1	0.005
Mesothelioma	Note ..: not available for a specific reference period	Note ..: not available for a specific reference period	Note ..: not available for a specific reference period	Note ..: not available for a specific reference period	-4.0	-15.2	7.2	0.483	3.1	-4.7	10.9	0.438	2.2	-2.4	6.8	0.349	1.2	-5.4	7.8	0.722
.. not available for a specific reference period Note † data from Quebec have not been submitted to the Canadian Cancer Registry since the 2010 data year; net survival estimates for 2012-2014 predicted using the period method Return to note † referrer Note ‡ the province of Ontario did not submit in situ bladder cancer cases to the Canadian Cancer Registry prior to the 2010 data year Return to note ‡ referrer NOS=not otherwise specified Sources: Canadian Cancer Registry death linked file (1992-2014); life tables.

Date modified:: 2018-09-19

Language selection

Search and menus

Search

Table 4
Age-specific changes in five-year net survival, by selected cancer type, ages 15 to 84 years, Canada excluding Quebec, 1992-to-1994 to 2012-to-2014 period^{Table 4 Note †}

Table 4 Age-specific changes in five-year net survival, by selected cancer type, ages 15 to 84 years, Canada excluding Quebec, 1992-to-1994 to 2012-to-2014 periodTable 4 Note †

Note of appreciation

Standards of service to the public

Copyright

Table 4
Age-specific changes in five-year net survival, by selected cancer type, ages 15 to 84 years, Canada excluding Quebec, 1992-to-1994 to 2012-to-2014 period^{Table 4 Note †}